Mdtb Cell Manufacturing Gmbh
- Company typePrivate
- Founded-
- HeadquartersRadebeul, Germany
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Mdtb Cell Manufacturing Gmbh firmographics
Firmographics- Name
- Mdtb Cell Manufacturing Gmbh
- Legal name
- MDTB Cells GmbH
- Website
- https://mdtbcells.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Mdtb Cell Manufacturing Gmbh industry classification
Industry- Product category
- Cell Therapy / Advanced Therapy Medicinal Products (ATMP)
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Cell Therapy Manufacturing Services (GMP, autologous/allogeneic) (HLAAAKAC)
- akta.pro secondary industry
- Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)
Keywords
Where Mdtb Cell Manufacturing Gmbh is headquartered
LocationHeadquarters
- HQ city
- Radebeul
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Mdtb Cell Manufacturing Gmbh business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Pharmaceutical Drug Substances: Revenue from manufacturing and supplying allogeneic MSC-based drug substances (Desacell) for clinical trials and eventual approved medicines. The company produces pharmaceutical-grade ready-to-use products for various indications including sepsis, lung diseases, GvHD, and other inflammatory conditions.
- Clinical Trial Support Products: Revenue from providing investigational medicinal products (IMP) for clinical studies in adults and children across multiple indications. Products supplied in any dosage/concentration for clinical trial purposes.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
Mdtb Cell Manufacturing Gmbh product offering
Product offeringCore offering
MDTB Cell Manufacturing GmbH develops and manufactures GMP-compliant allogeneic mesenchymal stromal cell (MSC) drug substances and advanced therapy medicinal products using its Desacell® platform. The company processes donated umbilical cord tissue via a proprietary closed GMP inline system to produce pharmaceutical-grade, off-the-shelf bedside-ready MSC medicines for inflammation- and age-related diseases including sepsis, lung disease, GvHD, myocardial infarction, and osteoarthritis.
Product overview
MDTB Cells is a group of pharmaceutical companies developing and manufacturing MSC-based (mesenchymal stromal cells) immunomodulating drug substances and advanced therapy medicinal products (ATMP). The core product is Desacell®, an allogeneic umbilical cord tissue-derived MSC platform (Huc-msc) that serves as the active ingredient for multiple therapeutic applications. The product portfolio includes named drug candidates: PNEUMOX® (Desacell® gamma) for lung diseases, CELASEPS® (Desacell® alfa) for septic shock, and ETRECIX® for GvHD, plus products for myocardial infarction and osteoarthritis. The company also provides clinical trial investigational medicinal products and preclinical R&D services. The manufacturing approach uses a closed GMP inline system for scaled, cost-efficient production from donated umbilical cord tissue.
Differentiator
Problem solved
Functional benefit
Brands
- Desacell®: Allogeneic umbilical cord tissue-derived mesenchymal stromal cells (Huc-msc) drug substance for treating inflammation- and age-related diseases.
- PNEUMOX®
- CELASEPS®
- ETRECIX®
Products and services
- Desacell® Allogeneic, ex vivo expanded MSC drug substance derived from donated umbilical cord tissue; the primary active ingredient used across the company's therapeutic pipeline for inflammation- and age-related diseases.
- PNEUMOX® (Desacell® gamma) Immunomodulating MSC medicine based on Desacell® gamma for treatment of lung disease (BPD/CLD) in premature infants and adults.
- CELASEPS® (Desacell® alfa) Immunomodulating MSC medicine based on Desacell® alfa for treatment of septic shock.
- ETRECIX® Immunomodulating MSC medicine for treatment of Graft-versus-Host Disease (GvHD) following transplantation.
- Clinical Trial Investigational Medicinal Products (IMP) Pharmaceutical-grade ready-to-use allogeneic MSC products supplied to clinical study sponsors and sites for adult and pediatric trials across multiple indications, available in any dosage or concentration.
Quantifiable outcome
- Active clinical trial UC-CISS II (NCT0596927) for sepsis and septic shock with patients actively recruiting and all doses produced
Companies that use Mdtb Cell Manufacturing Gmbh
Customer profileSegments3 records
Ideal customer profiles2 records
Mdtb Cell Manufacturing Gmbh technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Mdtb Cell Manufacturing Gmbh partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and supporting.
- University Hospital Dresden (UKD)coreFounding academic institution and spin-off partner. UKD provided the foundational research expertise and clinical experience in MSC production that led to MDTB Cell Manufacturing GmbH's establishment. The hospital has many years of experience in MSC production.
- Center for Regenerative Therapies Dresden (CRTD)coreResearch center providing technical and scientific expertise as founding spin-off partner. CRTD has long-standing experience in MSC production and regenerative medicine research, contributing to the company's proprietary manufacturing capabilities.
- Contract Manufacturing Organizations (CMO)supportingExternal manufacturing partners that MDTB Cell Manufacturing GmbH collaborates with to support industrial-scale GMP production of MSC-based medicines and drug substances.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Mdtb Cell Manufacturing Gmbh competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Mdtb Cell Manufacturing Gmbh social profiles
Digital presenceMdtb Cell Manufacturing Gmbh financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mdtb Cell Manufacturing Gmbh leadership team
Management profileNumber of profiles
Profiles1 record
Mdtb Cell Manufacturing Gmbh funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mdtb Cell Manufacturing Gmbh M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mdtb Cell Manufacturing Gmbh
What does Mdtb Cell Manufacturing Gmbh do?
MDTB Cell Manufacturing GmbH develops and manufactures GMP-compliant allogeneic mesenchymal stromal cell (MSC) drug substances and advanced therapy medicinal products using its Desacell® platform. The company processes donated umbilical cord tissue via a proprietary closed GMP inline system to produce pharmaceutical-grade, off-the-shelf bedside-ready MSC medicines for inflammation- and age-related diseases including sepsis, lung disease, GvHD, myocardial infarction, and osteoarthritis.
Is Mdtb Cell Manufacturing Gmbh a public or private company?
Mdtb Cell Manufacturing Gmbh is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Mdtb Cell Manufacturing Gmbh founded?
Mdtb Cell Manufacturing Gmbh was founded in -1. It employs 1 to 10 people.
Where is Mdtb Cell Manufacturing Gmbh based?
Mdtb Cell Manufacturing Gmbh is headquartered in Radebeul, Germany, in the Europe region.
How does Mdtb Cell Manufacturing Gmbh make money?
Two revenue lines are on record. Pharmaceutical Drug Substances are the primary driver. The others are clinical Trial Support Products.
Does Mdtb Cell Manufacturing Gmbh have an API?
No public API is recorded for Mdtb Cell Manufacturing Gmbh.
What industry is Mdtb Cell Manufacturing Gmbh in?
Mdtb Cell Manufacturing Gmbh's product category is Cell Therapy / Advanced Therapy Medicinal Products (ATMP). Its primary akta.pro industry code is HLAAAKAC, Cell Therapy Manufacturing Services (GMP, autologous/allogeneic), with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 325414 and its SIC code is 2836.